Stock Events

Stock Events

Heron Therapeutics (AXD2.F) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.14

-0.1

-0.06

-0.02

Details

Expected EPS

-0.06930825

Actual EPS

-0.018600000000000002

Surprise EPS

0.05

Surprise Percent

+73.16%

Description

Heron Therapeutics (AXD2.F) has reported earnings of -0.018600000000000002 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.